2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide
C19H14ClN7OS — CID 174175037
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide
2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide (PubChem CID 174175037) has the molecular formula C19H14ClN7OS and a molecular weight of 423.89 g/mol. Its IUPAC name is 2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide.
Molecular Properties
| Compound Name | 2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 174175037 |
| Molecular Formula | C19H14ClN7OS |
| Molecular Weight | 423.89 g/mol |
| Exact Mass | 423.07 |
| IUPAC Name | 2-(5-amino-2-chloro-4-pyridinyl)-3-[[5-(1,3-thiazol-4-yl)pyrimidin-2-yl]amino]benzamide |
| SMILES | NC(=O)c1cccc(Nc2ncc(-c3cscn3)cn2)c1-c1cc(Cl)ncc1N |
| InChI | InChI=1S/C19H14ClN7OS/c20-16-4-12(13(21)7-23-16)17-11(18(22)28)2-1-3-14(17)27-19-24-5-10(6-25-19)15-8-29-9-26-15/h1-9H,21H2,(H2,22,28)(H,24,25,27) |
| InChIKey | FBXPFENLGNECMN-UHFFFAOYSA-N |
| XLogP | 3.74 |
| TPSA | 132.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.89 |
| LogP ≤ 5 | 3.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174175037 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.